期刊文献+

CYP19基因多态性与新疆维、汉民族女性乳腺癌易感性及临床病理指标的关系

暂未订购
导出
摘要 目的探讨CYP19 rs10046位点基因多态性与新疆维、汉民族女性乳腺癌易感性及临床病理指标的关系.方法选择汉族女性乳腺癌患者、维吾尔族正常女性、汉族正常女性以及维吾尔族女性乳腺癌患者各100例,检测 CYP19 rs10046 位点基因多态性,并对比检测结果.结果在维、汉族各亚组中,病例组与对照组的基因型分布及等位基因频率均无统计学差异(P〉0.05);维、汉两民族病例组与对照组的各基因型及等位基因均未增加患乳腺癌的风险.结论在病例组及对照组中,维、汉两民族CYP19基因型分布及等位基因频率无显著差异.CYP19 rs10046位点基因多态性与新疆维、汉民族女性乳腺癌的发生有关. ObjectiveTo investigate the polymorphism of rs10046 CYP19 locus and the susceptibility of breast cancer in Xinjiang Uygur and Han ethnic women.The relationship between clinical pathological indexes. MethodsHan female breast cancer patients, and Uygur normal women and Han women and Uygurs women with breast cancer patients with 100 cases in each, the detection of CYP19 rs10046 polymorphism, and contrast detection results. Resultsin Uygur and Han subgroups, the case group and the control group of genotype distribution and allele frequency showed no significant difference (P 〉 0.05); in Uygur and Han nationality patients and control group of each genotype and allele was not increased the risk of breast cancer. Conclusionin the case group and control group, two Uygur and Han nationality CYP19 genotype distribution and allele frequency have no significant difference. CYP19 rs10046 gene polymorphism and Xinjiang Uygur and Han nationality women with breast cancer.
出处 《湖南中医药大学学报》 CAS 2016年第A01期22-23,共2页 Journal of Hunan University of Chinese Medicine
基金 新疆维吾尔自治区自然科学基金项目(2013211A068)
关键词 乳腺癌 CYP19基因 基因多态性 维吾尔族 汉族 breast cancer CYP19 gene gene polymorphism Uygur nationality Han nationality
  • 相关文献

参考文献3

二级参考文献31

  • 1宋传贵,胡震,袁文涛,狄根红,沈镇宙,黄薇,邵志敏.CYP19A1基因R264C在中国上海BRCA1/2基因突变阴性的遗传倾向乳腺癌中的作用[J].中华医学遗传学杂志,2006,23(2):181-183. 被引量:4
  • 2Kocabas NA, Sardas S, Cholerton S, et al. Cytochrome p450 CYP 1B 1 and catecholomenghyl transferase (COMT) genetic poly- morphisms and breast cancer susceptibility in a Turkish population [J]. Arch Toxicol, 2002,76( 11): 643-649.
  • 3Ahsan H, Chen Y, Whittemore AS, et al. A family-based genetic association study of variants in estrogen metabolism genes COMT and C YP1 B 1 and breast cancer risk breast cancer[ J ].Res Treat, 2004,85(2) : 121-131.
  • 4Rudqvist TR, Wedren S, Granath F, et al. Cytochrome P4501B1 gene polymorphisms and postmenopausal breast cancer risk [ J ]. Carcinogenesis, 2003,24(9) : 1533-1539.
  • 5Zheng W, Xie DW, Jin F, et al. Genetic polymorphism of cyto- chrome P450-1B1 and risk of breast cancer[J]. Cancer Epidemiol Biomarkers Prey, 2000,9(2) : 147-150.
  • 6Wen WQ, Cai QY, Shu XQ, et al. Cytochrome P4501B1 and catecholomethyl transferase genetic polymorphisms and breast cancer risk in Chinese women: results from the Shanghai breast cancer study and a meta--analysis [ J ]. Cancer Epidemiol Biom Prey,2005,14(2) :329-335.
  • 7Pedraza AM,Pollan M,Pastor-Barriuso R,et al.Disparities inbreast cancer mortality trends in a middle income country[J],Breast Cancer Res Treat,2012,134(3):1190-1207.
  • 8Song M,Lee KM,Kang D.Breast cancer prevention based ongene-environment interaction[J].Mol Carcinog,2011?50(4);280-290.
  • 9Martin AM,Weber BL.Genetic and hormonal risk factors in breastcancer[J].J Nati Cancer Inst,2000,92(14):1126-1135.
  • 10Rodrigues P,Furriol J,Tormo E,et al.The single-nucleotidepolymorphisms +936 C/T VEGF and 2710 C/T VEGFRl areassociated with breast cancer protection in a Spanish population[J].Breast Cancer Res Treat,2012,133(2):769-778.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部